Literature DB >> 24659753

Bone marrow oedema assessment by magnetic resonance imaging in rheumatoid arthritis wrist and metacarpophalangeal joints: the importance of field strength, coil type and image resolution.

Simon Krabbe1, Iris Eshed2, Susanne Juhl Pedersen2, Pernille Bøyesen2, Jakob M Møller2, Flemming Therkildsen2, Mette Bjørndal Axelsen2, Ole Rintek Madsen2, Mikkel Østergaard2.   

Abstract

OBJECTIVE: The aim of this study was to examine the influence of different MRI unit field strengths, coil types and image resolutions on the OMERACT RA MRI scoring system (RAMRIS) of bone marrow oedema (BME) and image quality.
METHODS: Forty-one patients and 12 healthy controls participated in this cross-sectional study. Coronal short tau inversion recovery (STIR) and T1-weighted sequences were obtained at 0.23, 0.6, 1.5 and 3T using flex coils (Flex). Additional STIR sequences were obtained with phased array extremity coils (Extr) (at 0.6 and 1.5T) and higher resolution (at 1.5T). In otal, 338 STIR image sets were anonymized and scored according to RAMRIS and parameters of image quality were measured.
RESULTS: The BME sum scores were similar overall when comparing the different MRI units, coil types and voxel sizes, yet significantly higher at the higher resolution of 1.5T Extr compared with 0.23T Flex (P = 0.004), 0.6T Flex (P = 0.03), 1.5T Flex (P = 0.05) and 3T Flex (P = 0.001). Mean differences were relatively minor (0-3.5). Intrareader reliability of BME scores was high [intraclass correlation coefficient ≥ 0.90 for all except 0.23T (0.81) and percentage exact agreement 81-88%]. The smallest detectable difference was better at 0.6, 1.5 and 3T (9-29% of maximum value) than at 0.23T (40%). Image quality was lowest at 0.23T.
CONCLUSION: No major, consistent differences were found between BME scores using STIR sequences obtained at different field strengths, coil types and image resolutions, suggesting that these are equally suited for assessment of BME in RA. However, parameters of image quality and intrareader reliability (favouring 0.6, 1.5 and 3T) should be considered when selecting the MRI acquisition strategy.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  RAMRIS; arthritis; bone marrow oedema; magnetic resonance imaging; osteitis; rheumatoid arthritis

Mesh:

Year:  2014        PMID: 24659753     DOI: 10.1093/rheumatology/keu029

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

1.  Influence of field strength, coil type and image resolution on assessment of synovitis by unenhanced MRI--a comparison with contrast-enhanced MRI.

Authors:  Iris Eshed; Simon Krabbe; Mikkel Østergaard; Pernille Bøyesen; Jakob M Møller; Flemming Therkildsen; Ole Rintek Madsen; Mette Axelsen; Susanne Juhl Pedersen
Journal:  Eur Radiol       Date:  2014-12-24       Impact factor: 5.315

Review 2.  Dual energy CT in musculoskeletal applications beyond crystal imaging: bone marrow maps and metal artifact reduction.

Authors:  Gaurav Cheraya; Salil Sharma; Avneesh Chhabra
Journal:  Skeletal Radiol       Date:  2022-02-02       Impact factor: 2.199

3.  Osteitis: a retrospective feasibility study comparing single-source dual-energy CT to MRI in selected patients with suspected acute gout.

Authors:  Torsten Diekhoff; Michael Scheel; Sandra Hermann; Jürgen Mews; Bernd Hamm; Kay-Geert A Hermann
Journal:  Skeletal Radiol       Date:  2016-11-21       Impact factor: 2.199

4.  Outcome of Teriparatide Treatment on Fracture Healing Complications and Symptomatic Bone Marrow Edema in Four Adult Patients With Hypophosphatasia.

Authors:  Tobias Schmidt; Tim Rolvien; Carolin Linke; Nico Maximilian Jandl; Ralf Oheim; Michael Amling; Florian Barvencik
Journal:  JBMR Plus       Date:  2019-08-28

5.  TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol.

Authors:  Ellis Niemantsverdriet; Yousra J Dakkak; Leonie E Burgers; Femke Bonte-Mineur; Gerda M Steup-Beekman; Sjoerd M van der Kooij; Hido D Boom; Cornelia F Allaart; Pascal H P de Jong; Annette H M van der Helm-van Mil
Journal:  Trials       Date:  2020-10-16       Impact factor: 2.279

6.  Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia.

Authors:  D I Krijbolder; M Verstappen; F Wouters; L R Lard; Pdm de Buck; J J Veris-van Dieren; J L Bloem; M Reijnierse; Ahm van der Helm-van Mil
Journal:  Scand J Rheumatol       Date:  2021-07-15       Impact factor: 3.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.